Ermolenko V M, Nikiforova N V, Kukhtevich A V, Lifshits N L, Strunin S E
Ter Arkh. 1987;59(12):104-7.
The authors' and literature data on hormonal imbalance in uremia are analysed. The pathogenesis, clinical and laboratory signs and present-day methods of correction of renal osteodystrophy, anemia, arterial hypertension, derangements of carbohydrate and lipid metabolism, and hypogonadism developing as complications of chronic renal insufficiency (CRI), are considered. Increased potentialities of pharmacological correction of the above endocrine disturbances in CRI have been shown.
分析了作者及文献中关于尿毒症激素失衡的数据。探讨了慢性肾功能不全（CRI）并发症所导致的肾性骨营养不良、贫血、动脉高血压、碳水化合物和脂质代谢紊乱以及性腺功能减退的发病机制、临床和实验室指标及当前的纠正方法。已表明在CRI中对上述内分泌紊乱进行药物纠正的潜力有所增加。
